Your browser doesn't support javascript.
loading
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Stuver, Robert; Horwitz, Steven M; Advani, Ranjana H; Vose, Julie M; Lee, Hun Ju; Mehta-Shah, Neha; Zain, Jasmine M; Haverkos, Bradley; Lechowicz, Mary Jo; Moskowitz, Alison J; Pham, Luu Q; Leyden, Elizabeth; Ansell, Stephen M; Lunning, Matthew A.
Afiliação
  • Stuver R; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA.
  • Horwitz SM; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA.
  • Advani RH; Stanford University, Stanford, California, USA.
  • Vose JM; University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Lee HJ; MD Anderson Cancer Center, Houston, Texas, USA.
  • Mehta-Shah N; Washington University in St. Louis, St. Louis, Missouri, USA.
  • Zain JM; City of Hope, Duarte, California, USA.
  • Haverkos B; University of Colorado, Boulder, Colorado, USA.
  • Lechowicz MJ; Emory University, Atlanta, Georgia, USA.
  • Moskowitz AJ; Memorial Sloan Kettering Cancer Center, Manhattan, New York, USA.
  • Pham LQ; Oakland University William Beaumont School of Medicine, Rochester, Michigan, USA.
  • Leyden E; University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Ansell SM; Mayo Clinic, Rochester, Minnesota, USA.
  • Lunning MA; University of Nebraska Medical Center, Omaha, Nebraska, USA.
Br J Haematol ; 202(3): 525-529, 2023 08.
Article em En | MEDLINE | ID: mdl-37217196

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article